@1009 ?5:95751753 ?six TAC-TAG@693 ?Truncated Truncated Truncated five:95768745 ?1 ATG-ACG@2 ?Truncated Homozygous Homozygous Homozygous Homozygous #6a/6b #10 #4 #5a/#5bp.M1Xp.Y231Xp.Q337Xp.R405XDELETION: c.1349_1352delTGGA 5:95735735-38 ?ten GTGGAT-GTTTAG@1349 ?Deletion Homozygous #p.V450fsXSPLICE Internet site: c.1095+1T c.1095+1A 5:95746477 ?I-8 |GTA-ATA 5:95746477 ?I-8 |GTA-TTA ??Intron donor site loss Intron donor website loss Homozygous Homozygous #3 #IVS8+1GTGastroenterology. Author manuscript; out there in PMC 2014 July 01.IVS8+1GANIH-PA Author ManuscriptPageNIH-PA Author ManuscriptNIH-PA Author Manuscript
Volume 15 NumberneoplasiaJulypp. 783?94Functional Role and Therapeutic Possible with the Pim-1 Kinase in Colon Carcinoma1,Ulrike Weirauch* , Nadine Beckmann* , Maren Thomas , Arnold Gr weller , ??Kilian Huber , Franz Bracher , , Roland K. Hartmann and Achim Aigner**Rudolf Boehm Institute for Pharmacology and Toxicology, Clinical Pharmacology, University of Leipzig, Leipzig, Germany; Pharmacological Institute, Philipps University Marburg, Marburg, Germany; Institute of Pharmaceutical Chemistry, Philipps University Marburg, Marburg, Germany; �Department of Pharmacy, Center for Drug Analysis, Ludwig Maximilians University Munich, Munich, Germany,,Abstract Purpose: The provirus integration web site for Moloney murine leukemia virus 1 (Pim-1) kinase is overexpressed in several tumors and has been linked to poor prognosis. Its role as proto-oncogene is based on quite a few Pim-1 target proteins involved in pivotal cellular processes.Formula of 5-Hydroxymethylfurfural Here, we discover the functional relevance of Pim-1 in colon carcinoma.trans-Hexahydro-1H-furo[3,4-c]pyrrole Order EXPERIMENTAL Design: RNAi-based knockdown approaches, too as a precise tiny molecule inhibitor, have been employed to inhibit Pim-1 in colon carcinoma cells. The effects have been analyzed relating to proliferation, apoptosis, sensitization toward cytostatic treatment, and general antitumor impact in vitro and in mouse tumor models in vivo. Benefits: We demonstrate antiproliferative, proapoptotic, and all round antitumor effects of Pim-1 inhibition. The sensitization to 5-fluorouracil (5-FU) therapy upon Pim-1 knockdown delivers new possibilities for combinatorial treatment approaches.PMID:23543429 Importantly, this also antagonizes a 5-FU riggered Pim-1 up-regulation, which is mediated by decreased levels of miR-15b, a microRNA we newly determine to regulate Pim-1. The evaluation in the molecular effects of Pim-1 inhibition reveals a complex regulatory network, with therapeutic Pim-1 repression major to main changes in oncogenic signal transduction with regard to p21Cip1/WAF1, STAT3, c-jun-N-terminal kinase (JNK), c-Myc, and survivin and within the levels of apoptosis-related proteins Puma, Bax, and Bcl-xL. CONCLUSIONS: We demonstrate that Pim-1 plays a pivotal role in many tumor-relevant signaling pathways and establish the functional relevance of Pim-1 in colon carcinoma. Our benefits also substantiate the RNAi-mediated Pim-1 knockdown based on polymeric polyethylenimine/ compact interfering RNA nanoparticles as a promising therapeutic strategy.Neoplasia (2013) 15, 783?Abbreviations: PEI, polyethylenimine; 5-FU, 5-fluorouracil; siRNA, small interfering RNA; miRNA, microRNA Address all correspondence to: Dr Achim Aigner, Rudolf Boehm Institute for Pharmacology and Toxicology, Clinical Pharmacology, University of Leipzig, Haertelstrasse 16-18, D-04107 Leipzig, Germany. E-mail: [email protected] 1 This operate was supported by grants in the German Cancer Aid (Deutsche Kre.